Status: Recruiting
To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors
The purpose of this study is to evaluate the preliminary efficacy, safety, tolerability and pharmacokinetics of KC1036 in participants with advanced recurrent or metastatic digestive system tumors.
Participants needed: 133
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Beijing Konruns Pharmaceutical Co., Ltd.Updated: Oct 17, 2024Locations: 13
Eligibility criteria
Histologically or cytologically confirmed malignant digestive system tumors; [+6]
Any patient who is known to have central nervous system (CNS) metastasis with cl... [+13]